The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Cripto 在乳腺癌和结肠癌发病机制中的作用
基本信息
- 批准号:7592590
- 负责人:
- 金额:$ 137.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseActivinsAdenocarcinomaAdultAnteriorAntibodiesAppearanceBindingBiological ProcessBreastBreast CarcinomaBreast HyperplasiaCFC1 geneCellsCervicalColonColon CarcinomaDisease ProgressionDuctal Epithelial CellEmbryoEmbryonic DevelopmentEndodermEpithelialEpithelial CellsEyeFemaleGastric AdenomaGene FamilyGenesGenetic TranscriptionGenus ColaGlypicanHeparitin SulfateHistologicHumanHuman MilkIntestinal MetaplasiaIntraductal HyperplasiaInvasiveLactationLeftLesionLinkLuciferasesMAP Kinase GeneMalignant neoplasm of lungMammary glandMesenchymalMesodermMorphogenesisMouse Mammary Tumor VirusMultigene FamilyMusNeoplasm MetastasisNodalNoninfiltrating Intraductal CarcinomaOvarianPancreasPapillaryPathogenesisPhase I Clinical TrialsPhosphorylationPlasmaPregnancyPremalignantProtein OverexpressionProteinsProteoglycanRecombinantsRegulationReporterResearchRoleSRC geneSignal PathwayStomachTissuesToxin ConjugatesTransgenesVimentinXenopusZebrafishadult stem cellangiogenesisbeta catenincell motilitycompetence factordesignembryonic stem cellepithelial to mesenchymal transitionglycogen synthase kinase 3 betahuman NTN1 proteinlung Carcinomaneoplastic cellnetrin-1novelprogramspromoterreceptorrelating to nervous system
项目摘要
The EGF-CFC gene family encodes a group of structurally related proteins that serve as important competence factors during early embryogenesis in Xenopus, zebrafish, mice and humans. This multigene family consists of Xenopus FRL-1, zebrafish one-eyed-pinhead (oep ), mouse cripto (Cr-1) and cryptic and human cripto (CR-1) and criptin. FRL-1, oep and mouse cripto are essential for the formation of mesoderm and endoderm and for correct establishment of the embryonic anterior/posterior axis. In addition, oep and cryptic are important for the establishment of left-right asymmetry. In the mouse cryptic is not expressed in adult tissues whereas Cr-1 is expressed at a low level in several different tissues including the mammary gland. In the mammary gland, expression of Cr-1 in the ductal epithelial cells increases during pregnancy and lactation and immunoreactive and biologically active Cr-1 protein can be detected in human milk. Overexpression of a human CR-1 transgene in the mouse mammary gland using an MMTV orWAP promoter results in the appearance of ductal hyperplasias in the mammary gland and papillary amd histologically mixed subtypes of adenocarcinomas in multiparous female mice. Recombinant mouse or human cripto can enhance cell motility and branching morphogenesis in mouse mammary epithelial cells and in some human tumor cells. These effects are accompanied by an epithelial-mesenchymal transition which is associated with a decrease in beta-catenin adherens function and an increase in vimentin expression. Expression of CR-1 is increased several-fold in human colon, gastric, pancreatic, cervical, ovarian and lung carcinomas and in a variety of different types of mouse and human breast carcinomas. More importantly, this increase in cripto-1 expression can first be detected in premalignant lesions in some of these tissues such as in the breast ( hyperplasias and DCIS ), colon ( adenomas ) and stomach <BR>( intestinal metaplasias ). We have recently identied the Activin ALK4 type 1 receptor as a co-receptor for CR-1 which presents Nodal to ALK4 and thereby can stimulate Smad-2 phosphorylation and transcription through an SBE-luciferase reporter construct.In addition, CR-1 can function through a Nodal and ALK4-independent signaling pathway and activate MAPK, PI-3 kinase and Akt by binding to the GPI-linked heparan sulphate-containing proteoglycan, glypican-1 which can then activate c-src. Activation of MAPK, PI-3 kinase, GSK-3beta and Akt in mammary epithelial cells by CR-1 are required for the ability of CR-1 to stimulate epithelial to mesenchymal transition, cell migration and cell invasion which is invovled in metastasis and angiogenesis. The invasive effects of CR-1 can be antagonized by the neural guidance protein Netrin-1 through the UNC5b receptor in mammary epithelial cells. CR-1 is also invovled in maintaing embryonic stem cell pluripotentiality and may perform a similar function in adult stem cells in the mammary gland and colon. CR-1 can be found at significant levels in the plasma of breast and colon cancer paptients and may therefore represent a novel marker to detect the onset or progression of these diseases.
EGF-CFC基因家族编码一组结构相关的蛋白质,在非洲爪蟾、斑马鱼、小鼠和人类的早期胚胎发生中作为重要的感受态因子。这个多基因家族包括非洲爪蟾FRL-1、斑马鱼独眼针头(oep)、小鼠cripto(Cr-1)和隐蔽的cripto(CR-1)以及人criptin。FRL-1、oep和小鼠cripto对中胚层和内胚层的形成以及胚胎前/后轴的正确建立至关重要。另外,oep和cryptic对左右不对称的建立也很重要。在小鼠中,隐蔽蛋白在成体组织中不表达,而Cr-1在包括乳腺在内的几种不同组织中以低水平表达。在乳腺中,在妊娠和哺乳期间导管上皮细胞中Cr-1的表达增加,并且在人乳中可以检测到免疫反应性和生物活性Cr-1蛋白。使用MMTV或WAP启动子在小鼠乳腺中过表达人CR-1转基因导致在经产雌性小鼠中出现乳腺导管增生和乳头状腺癌以及组织学上混合的腺癌亚型。重组小鼠或人cripto可以增强小鼠乳腺上皮细胞和一些人肿瘤细胞的细胞运动性和分支形态发生。这些作用伴随着上皮-间充质转化,其与β-连环蛋白粘附功能的降低和波形蛋白表达的增加相关。CR-1的表达在人结肠癌、胃癌、胰腺癌、宫颈癌、卵巢癌和肺癌以及各种不同类型的小鼠和人乳腺癌中增加数倍。更重要的是,cripto-1表达的这种增加可以首先在这些组织中的一些的癌前病变中检测到,例如在乳腺(增生和DCIS)、结肠(腺瘤)和胃<BR>(肠化生)中。我们最近鉴定了活化素ALK 4 1型受体作为CR-1的共受体,其将Nodal呈递给ALK 4,从而可以通过SBE-荧光素酶报告基因构建体刺激Smad-2磷酸化和转录。此外,CR-1可以通过Nodal和ALK 4非依赖性信号通路发挥作用,并通过结合GPI连接的含硫酸乙酰肝素的蛋白聚糖激活MAPK、PI-3激酶和Akt,磷脂酰肌醇蛋白聚糖-1,其然后可以激活c-src。CR-1激活乳腺上皮细胞中的MAPK、PI-3激酶、GSK-3 β和Akt是CR-1刺激上皮细胞向间质细胞转化、细胞迁移和细胞侵袭的能力所必需的,这与转移和血管生成有关。神经导向蛋白Netrin-1可通过乳腺上皮细胞中的UNC 5 b受体拮抗CR-1的侵袭作用。CR-1还参与维持胚胎干细胞的多能性,并且可能在乳腺和结肠中的成体干细胞中执行类似的功能。CR-1在乳腺癌和结肠癌患者的血浆中可以发现显著水平,因此可能代表检测这些疾病的发作或进展的新标记物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID SALOMON其他文献
DAVID SALOMON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID SALOMON', 18)}}的其他基金
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Cripto 在乳腺癌和结肠癌发病机制中的作用
- 批准号:
7732932 - 财政年份:
- 资助金额:
$ 137.12万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Col
Cripto 在乳腺和结肠发病机制中的作用
- 批准号:
7292123 - 财政年份:
- 资助金额:
$ 137.12万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Cripto 在乳腺癌和结肠癌发病机制中的作用
- 批准号:
6433130 - 财政年份:
- 资助金额:
$ 137.12万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Cripto 在乳腺癌和结肠癌发病机制中的作用
- 批准号:
7965131 - 财政年份:
- 资助金额:
$ 137.12万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Cripto 在乳腺癌和结肠癌发病机制中的作用
- 批准号:
8348915 - 财政年份:
- 资助金额:
$ 137.12万 - 项目类别:
THE ROLE OF EGF-RELATED PEPTIDES IN THE PATHOGENESIS OF BREAST AND COLON CANCER
EGF 相关肽在乳腺癌和结肠癌发病机制中的作用
- 批准号:
6289225 - 财政年份:
- 资助金额:
$ 137.12万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Col
Cripto 在乳腺和结肠发病机制中的作用
- 批准号:
7338127 - 财政年份:
- 资助金额:
$ 137.12万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Cripto 在乳腺癌和结肠癌发病机制中的作用
- 批准号:
8552609 - 财政年份:
- 资助金额:
$ 137.12万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Col
Cripto 在乳腺和结肠发病机制中的作用
- 批准号:
6762087 - 财政年份:
- 资助金额:
$ 137.12万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Cripto 在乳腺癌和结肠癌发病机制中的作用
- 批准号:
8157216 - 财政年份:
- 资助金额:
$ 137.12万 - 项目类别:
相似海外基金
Effects of activins and activin-binding proteins on fetal lung development
激活素和激活素结合蛋白对胎儿肺发育的影响
- 批准号:
23K08875 - 财政年份:2023
- 资助金额:
$ 137.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Activins to treat cachexia
靶向激活素治疗恶病质
- 批准号:
nhmrc : 1078907 - 财政年份:2015
- 资助金额:
$ 137.12万 - 项目类别:
Project Grants
Targeting Activins to treat cachexia
靶向激活素治疗恶病质
- 批准号:
nhmrc : GNT1078907 - 财政年份:2015
- 资助金额:
$ 137.12万 - 项目类别:
Project Grants
INTERACTIONS OF ACTIVINS AND BMP WITH THEIR RECEPTORS
激活素和 BMP 与其受体的相互作用
- 批准号:
7537247 - 财政年份:2007
- 资助金额:
$ 137.12万 - 项目类别:
INTERACTIONS OF ACTIVINS AND BMP WITH THEIR RECEPTORS
激活素和 BMP 与其受体的相互作用
- 批准号:
6849106 - 财政年份:2003
- 资助金额:
$ 137.12万 - 项目类别:
ROLE OF ACTIVINS IN BRANCHING MORPHOGENESIS OF THE PROSTATE AND OTHER ORGANS
激活素在前列腺和其他器官分支形态发生中的作用
- 批准号:
nhmrc : 7191 - 财政年份:2001
- 资助金额:
$ 137.12万 - 项目类别:
Early Career Fellowships
Biology of activins in fetoplacental hypoxia
胎儿胎盘缺氧中激活素的生物学
- 批准号:
nhmrc : 143769 - 财政年份:2001
- 资助金额:
$ 137.12万 - 项目类别:
NHMRC Postgraduate Scholarships
Roles of inhibins, activins, and follistation in reproductive systems.
抑制素、激活素和卵泡在生殖系统中的作用。
- 批准号:
10460135 - 财政年份:1998
- 资助金额:
$ 137.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
FUNCTIONAL ANALYSIS OF ACTIVINS DURING DEVELOPMENT
发育过程中激活素的功能分析
- 批准号:
6125677 - 财政年份:1994
- 资助金额:
$ 137.12万 - 项目类别:
FUNCTIONAL ANALYSIS OF ACTIVINS DURING DEVELOPMENT
发育过程中激活素的功能分析
- 批准号:
6476789 - 财政年份:1994
- 资助金额:
$ 137.12万 - 项目类别: